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Mitochondria are organelles centrally important for
bioenergetics as well as regulation of apoptotic
death in eukaryotic cells. High-mobility group box 1
(HMGB1), an evolutionarily conserved chromatin-
associated protein which maintains nuclear homeo-
stasis, is also a critical regulator of mitochondrial
function and morphology. We show that heat shock
protein beta-1 (HSPB1 or HSP27) is the downstream
mediator of this effect. Disruption of the HSPB1 gene
in embryonic fibroblasts with wild-type HMGB1
recapitulates the mitochondrial fragmentation, defi-
cits in mitochondrial respiration, and adenosine
triphosphate (ATP) synthesis observed with targeted
deletion of HMGB1. Forced expression of HSPB1
reverses this phenotype in HMGB1 knockout cells.
Mitochondrial effects mediated by HMGB1 regula-
tion of HSPB1 expression serve as a defense against
mitochondrial abnormality, enabling clearance and
autophagy in the setting of cellular stress. Our find-
ings reveal an essential role for HMGB1 in autopha-
gic surveillance with important effects on mitochon-
drial quality control.
INTRODUCTION
Mitochondria play a primary role in bioenergetics in most
eukaryotic cells (Chan, 2006a). Gene products derived from
both the mitochondrial and nuclear genomes (Poyton and
McEwen, 1996) are necessary for the assembly and function of
respiratory-competent mitochondria. High-mobility group box
1 (HMGB1) is an evolutionarily conserved protein, found in abun-
dance within the nucleus. HMGB1 knockout mice die shortly
after birth with severe hypoglycemia, pointing to the essential
nature of the protein (Calogero et al., 1999). Within the nucleus,CHMGB1 binds and bends DNA, facilitating numerous nuclear
functions including maintenance of genome stability, transcrip-
tion, replication, recombination, and repair. HMGB1 plays a
role in neurodegeneration, aging, and cancer (Kang et al.,
2010b; Lotze and Tracey, 2005; Qi et al., 2007; Tang et al.,
2010c, 2011), which are often accompanied by mitochondrial
abnormalities (Chan, 2006b; Poyton and McEwen, 1996). It can
be rapidly mobilized to other sites in the cell as well as actively
released from cells. This study was initiated to determine
whether HMGB1 affects mitochondrial function.RESULTS AND DISCUSSION
To address this possibility, we first assessed real-time oxidative
phosphorylation (OXPHOS) by determining the oxygen con-
sumption rate (OCR) and glycolysis by measuring the extracel-
lular acidification rate (ECR) with an extracellular flux analyzer
(Qian and Van Houten, 2010; Wu et al., 2007) in Hmgb1+/+
wild-type and Hmgb1/ knockout immortalized mouse
embryonic fibroblasts (MEFs) (Figure 1A). Analysis of OCR and
ECR was performed in the presence of four individual inhibitors:
(1) oligomycin (Olig), which inhibits mitochondrial adenosine
triphosphate (ATP) synthesis; (2) p-trifluoromethoxy carbonyl
cyanide phenyl hydrazone (FCCP), which uncouples OXPHOS;
(3) 2-deoxyglucose (2DG), which inhibits hexokinase in the
glycolytic pathway; and (4) rotenone (Rote), which inhibits
complex I in the respiratory chain. There was a significant
decrease in basal OXPHOS and glycolysis with HMGB1 defi-
ciency (+/+ versus/, p < 0.001) (Figure 1B) aswell as substan-
tial decreases in reserve capacity (FCCP stimulated OCR). To
determine whether alterations in mitochondrial function are
directly due to the loss of HMGB1, we transfected a plasmid ex-
pressing HMGB1 and a downstream green fluorescent protein
(GFP) cDNA (to assess transfection efficiency) into Hmgb1/
MEFs. Expression of HMGB1 restored glycolysis, mitochondrial
respiration, and ATP production (Figures 1A–1C). To further rule
out the possibility that decreasedmitochondrial respiration in the
Hmgb1/ MEFs resulted from chronic metabolic or other unre-
lated genetic changes that may have occurred during clonalell Metabolism 13, 701–711, June 8, 2011 ª2011 Elsevier Inc. 701
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Figure 1. HMGB1 Sustains Cellular Bioenergetics and Normal Mitochondrial Morphology in MEFs
(A) Transient transfection of HMGB1 (pEGFPN1-HMGB1) or empty vector (pEGFPN1) into Hmgb1/MEFs increased HMGB1 protein expression after 48 hr by
western blot assay. +/+, Hmgb1+/+ MEFs; /, Hmgb1/ MEFs.
(B) Expression of HMGB1 restores normal cellular bioenergetics in Hmgb1/ MEFs. Cells were treated sequentially as indicated with oligomycin (Olig, 1 uM),
p-trifluoromethoxy carbonyl cyanide phenyl hydrazone (FCCP, 0.3 uM), 2-deoxyglucose (2DG, 100 mM) and rotenone (Rote, 1 uM). OCR, indicative of OXPHOS,
and ECR, indicative of glycolysis, were monitored by using the Seahorse Bioscience Extracellular Flux Analyzer in real time (mean ± SD, n = 3). +/+, Hmgb1+/+
MEFs; /, Hmgb1/ MEFs.
(C) ATP levels were assessed by using an ATP Assay Kit (PerkinElmer) in Hmgb1/ (/) MEFs with or without pEGFPN1 empty vector or pEGFPN1-HMGB1
transfection. Data represent relative ATP levels, with Hmgb1+/+ (+/+) MEFs set as 100% (mean ± SD, n = 3, *p < 0.01, ns, not significant).
(D) Knockout or knockdown of HMGB1 decreases cellular proliferation in MEFs and NIH 3T3 cells. Data are expressed as means ± SD.
(E) Mitochondrial (Mit) morphology was evaluated by using antibodies against mitochondrial complex I subunit GRIM-19 (red) with or without pUNO1 empty
vector or pUNO1-HMGB1 transfection. HMGB1 and the nucleus were stained by HMGB1 antibody (green) or Hoechst 33342 (blue), respectively. Mitochondrial
fragmentation (%) in Hmgb1+/+ (+/+) and Hmgb1/ (/) MEFs were quantified from 15–20 random fields. In parallel, the mitochondrial membrane potential was
assayed for JC-1 expression by flow cytometry (mean ± SD, n = 3, *p < 0.01, ns, not significant, Hmgb1+/+ group set as 1). The boxed areas represent expanded
regions (magnified) from the panels of the selected region by confocal imaging.
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HMGB1 and Mitochondria Quality Controlselection, we examined OCR and ECR after reducing HMGB1
expression by short hairpin RNA (shRNA). Decreased HMGB1
expression in parental MEFs, NIH-3T3 mouse fibroblasts,
Panc02 mouse, Panc2.03 human pancreatic cancer cells, or
human HCT116 colon cancer cells resulted in decreased
OXPHOS,phenocopyingHMGB1-deficient cells (Figures2and3).702 Cell Metabolism 13, 701–711, June 8, 2011 ª2011 Elsevier Inc.Furthermore, steady-state levels of ATP are decreased by
20–40% in Hmgb1/ or HMGB1 knockdown cells (Figures 1C,
2C, and 3C), which is accompanied by diminished cell growth
and proliferation (Figure 1D). To determine whether the deficiency
inmitochondrial respiration inHmgb1/cells isdue toadecrease
in mitochondrial mass, we quantified levels of representative
A B
O
CR
 (p
Mo
les
/m
in)
HMGB1 shRNACtrl shRNA
EC
R 
(m
pH
/m
in)
C
HMGB1
Actin
AT
P 
(%
)
*
Time (min) Time (min)
Olig 
FCCP Rote
2DG Olig 
FCCP Rote
2DG
M
EF
N
IH
3T
3
D
0
200
400
600
800
1000
0 40 80 120
0
200
400
600
0
20
40
60
0 40 80 120
0
20
40
60
O
CR
 (p
Mo
les
/m
in)
EC
R 
(m
pH
/m
in)
HMGB1 shRNA
Ctrl shRNA
*
AT
P 
(%
)
HMGB1
Actin
2: HMGB1 shRNA
1: Ctrl shRNA
1 2
1 2
30 µm 
MEF NIH3T3
HMGB1 shRNACtrl shRNA HMGB1 shRNACtrl shRNA
Mitochondria / Nucleus Mitochondria / Nucleus
0
20
40
60
80
100
120
0
20
40
60
80
100
120
Parkin
Parkin
Figure 2. HMGB1 Is Required to Sustain Cellular Bioenergetics and Mitochondrial Morphology in MEFs and NIH 3T3 Cells
(A) Western blot assay for HMGB1 expression in the indicated cells after transfection for 48 hr with control shRNA or HMGB1 shRNA.
(B) Knockdown of HMGB1 in MEFs or NIH 3T3 cells decreased OXPHOS. Cells were sequentially treated as indicated with oligomycin (Olig, 1 uM),
p-trifluoromethoxy carbonyl cyanide phenyl hydrazone (FCCP, 0.3 uM), 2-deoxyglucose (2DG, 100mM), and rotenone (Rote, 1 uM). OCR, indicative of OXPHOS,
and ECR, indicative of glycolysis, were monitored by using the Seahorse Bioscience Extracellular Flux Analyzer in real time (mean ± SD, n = 3).
(C) ATP levels were assessed by using an ATPAssay Kit (PerkinElmer Life Sciences) in control shRNA or HMGB1 shRNA-transfected cells. Data represent relative
ATP levels, with control shRNA group set as 100% (mean ± SD, n = 3, *p < 0.01).
(D) Mitochondrial morphology was evaluated by using antibody against the mitochondrial complex I subunit GRIM-19 (red) in control shRNA or HMGB1 shRNA-
transfected cells. Images are representative of 15–20 random fields. All data are representative of two or three experiments. Note in particular the fragmented
mitochondria and larger nuclei in Hmgb1/ cells.
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HMGB1 and Mitochondria Quality Controlproteins from complexes I–IV ‘(listed in Figure S1A, available
online) in Hmgb1+/+ and Hmgb1/ MEFs by immunoblotting. All
of the measured proteins were expressed at similar levels in
both cell types. In contrast, we observed an increase inmitochon-
drialmass inHmgb1/MEFsbyMitoTrackerGreen staining (Fig-
ure S1B) or Coomassie brilliant blue staining (Figure S1C).
Mitochondria are dynamic organelles and their morphologic
changes are tightly associated with their function (Chan,
2006a, 2006b). To assess the effect of HMGB1 on mitochondrial
morphology, we visualized mitochondrial architecture by using
immunohistochemistry with antibodies against complex I
subunit GRIM-19. Morphological analysis revealed that the
mitochondria, which exhibit long and tubular morphology in
Hmgb1+/+ cells, became dramatically shorter and rounder in
Hmgb1/ cells (Figure 1E). Moreover, expression of Hmgb1
cDNA in Hmgb1/ MEFs restored mitochondrial morphology.CHMGB1-deficient cells exhibit mitochondrial dysfunction with
respiratory deficits, a fragmented morphology, and loss in the
mitochondrial membrane potential (Figure 1E). In addition,
a balance between fission and fusion is critical to maintain
proper mitochondrial morphology and function. The key media-
tors of mitochondrial fusion and fission include dynamin-related
protein 1 (DRP1), fission 1 (FIS1), optic atrophy 1 (OPA1),
mitofusin 1 (MEN1), and mitofilin (Chan, 2006a, 2006b). All of
these mediators are present in similar amounts in whole-cell
lysate of both Hmgb1+/+ and Hmgb1/ cells (Figure S1A).
However, the short and long forms (S and L) of OPA1 (Suen
et al., 2008) are decreased in isolatedmitochondria of Hmgb1/
cells (Figure S1A).
Heat shock proteins (HSPs) and mitochondrial autophagy
(mitophagy) have also been proposed to regulate mitochondrial
dynamics and quality (Kim et al., 2007; Tatsuta and Langer,ell Metabolism 13, 701–711, June 8, 2011 ª2011 Elsevier Inc. 703
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Figure 3. HMGB1 and HSPB1 Are Required to Sustain OXPHOS in Pancreatic and Colon Tumor Cells
(A) Western blot assay for HMGB1 expression in the indicated cells after transfection for 48 hr with control shRNA, HMGB1 shRNA, or HSPB1 shRNA.
(B) Knockdown of HMGB1 or HSPB1 in pancreatic and colon tumor cells decreased OXPHOS (coincident curves below control). Cells were sequentially treated
as indicated with oligomycin (Olig, 1 uM), p-trifluoromethoxy carbonyl cyanide phenyl hydrazone (FCCP, 0.3 uM), 2-deoxyglucose (2DG, 100 mM), and rotenone
(Rote, 1 uM). OCR, indicative of OXPHOS, and ECR, indicative of glycolysis were monitored by using the Seahorse Bioscience Extracellular Flux Analyzer in real
time (mean ± SD, n = 3).
(C) ATP levels were assessed by using an ATP Assay Kit (PerkinElmer Life Sciences) in control shRNA, HMGB1 shRNA, or HSPB1 shRNA-transfected cells. Data
represent relative ATP levels, with the control shRNA group set as 100% (mean ± SD, n = 3, *p < 0.01 versus control shRNA group). All data are representative
of two or three experiments.
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HMGB1 and Mitochondria Quality Control2008; Youle and Narendra, 2011). The principal HSPs that have
chaperone activity belong to several families: HSP100 (e.g.,
HSP110), HSP90, HSP70, HSP60, HSP40, and the small heat-
shock proteins (e.g., HSP beta-1 [HSPB1], aB-crystallin, and
HSP27) (Craig et al., 1994; Sorger, 1991). In erythroid cells, NIX
(also known as BNIP3L), a member of the Bcl-2 gene family, is
required for mitophagy (Schweers et al., 2007). The protein
expression of HSPB1 (also known as HSP25 in mice and
HSP27 in humans), but not other HSPs or NIX, is significantly in-
hibited in Hmgb1/ cells (Figure 4A). Like HMGB1 (Calogero
et al., 1999),HSPB1 is expressed in variouscell typesand tissues,
and the failure to obtain knockout mice suggests that HSPB1 is
essential for growth and development (Arrigo, 2007; Garrido,
2002). Expression of HMGB1 restoredHSPB1mRNAandprotein
expression that were reduced in Hmgb1/ cells (Figure 4B).
Furthermore, we confirmed a similar HMGB1-dependent regula-
tion ofHSPB1protein expression after heat shock,whichwas not
observed in expression of HSP70 (Figure 4C). In both Hmgb1+/+
and Hmgb1/ cells, there are similar levels of heat shock factor
1 (HSF1), the major heat shock transcription factor that regulates
stress-inducible synthesis of HSPs (Sorger, 1991), and heat
shock element (HSE) activity (Figures 4A and 4D). These results
reveal that HSPB1 levels are regulated by HMGB1.704 Cell Metabolism 13, 701–711, June 8, 2011 ª2011 Elsevier Inc.To determine whether loss of HSPB1 can mimic HMGB1-defi-
ciency, we reduced HSPB1 expression levels by about 80% by
using two individual shRNA in Hmgb1+/+ MEFs when compared
with control shRNA. Decreased HSPB1 expression resulted in
reduced OCR, ECR (Figures 3B and 4E), ATP production
(Figures 3C and 4F), and increased mitochondrial fragmentation
(Figure 4G), which was remarkably similar to the phenotype
of HMGB1-deficient cells (Figure 1). To also determine whether
HMGB1 regulates mitochondrial quality directly through HSPB1,
we expressedmouse HSPB1 cDNA in Hmgb1/MEFs. Expres-
sion of HSPB1 in Hmgb1/ cells at the physiological level
observed in the Hmgb1+/+ cells (Figure 5A) corrected the deficit
in mitochondrial respiration (Figure 5B), ATP production (Fig-
ure 5C) and mitochondrial fragmentation (Figure 5D) observed
in HMGB1-deficient cells. This suggests that HSPB1 expression
can rescue the mitochondrial phenotype observed in HMGB1-
deficient cells.
The increased number of dysfunctional mitochondria in cells
deficient in HMGB1 thus appears to be due to the loss of one
of HMGB1’s transcriptional targets, HSPB1. Autophagy (which
includes macro-, micro-, and chaperone-mediated autophagy)
is an important biological mechanism for the elimination of
damaged or obsolete macromolecules and organelles (Kroemer
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Figure 4. Knockdown of HSPB1 Recapitu-
lates the HMGB1-Deficient Metabolic
Phenotype and Mitochondrial Morphology
(A) HMGB1 regulates HSPB1 but not other HSP
protein levels. Western blot analyses of HSPB1
and other proteins implicated in mitochondrial
morphology in Hmgb1+/+ (+/+) and Hmgb1/
(/) MEFs and MEFs or NIH3T3 cells transfected
with control shRNA or HMGB1 shRNA are shown.
(B) Dependence of HSPB1 protein and mRNA
transactivation levels on HMGB1. Transient
transfection of pUNO1-HMGB1 (HMGB1) into
Hmgb1/ MEFs restored HSPB1 protein
expression by western blot assay (top panel) and
HSPB1 mRNA expression by reverse transcription
polymerase chain reaction (bottom panel). +/+,
Hmgb1+/+ MEFs; /, Hmgb1/ MEFs.
(C) Western blot analysis of HSPB1 and HSP70
expression in Hmgb1+/+ and Hmgb1/ MEFs
after heat shock (60 min in a 42.5C water bath,
then 12 hr recovery).
(D) In parallel, heat shock element (HSE) activity
was evaluated in a luciferase reporter assay. Data
are expressed as means ± SD (n = 3). AU, arbitrary
unit.
(E) Knockdown of HSPB1 by shRNA reproduces
the bioenergetic phenotype observed in HMGB1-
deficient cells. The indicated cells were treated
sequentially with oligomycin (Olig, 1 uM), p-tri-
fluoromethoxy carbonyl cyanide phenyl hydrazone
(FCCP, 0.3 uM), 2-deoxyglucose (2DG, 100 mM)
and rotenone (Rote, 1 uM). OCR, indicative of
OXPHOS, and ECR, indicative of glycolysis, were
monitored by using the Seahorse Bioscience
Extracellular Flux Analyzer in real time (mean ± SD,
n=3). +/+,Hmgb1+/+MEFs;/, Hmgb1/MEFs.
(F) ATP levels were assessed in MEFs transfected
with HSPB1 shRNA. Data represent relative ATP
levels, with control shRNA MEFs set as 100%
(mean ± SD, n = 3, *p < 0.01 versus control shRNA
group).
(G) Mitochondrial morphology was evaluated by
using an antibody against the mitochondrial
complex I subunit GRIM-19 (red). Mitochondrial
fragmentation numbers (%) in cells were quantified
from 15–20 random fields (mean ± SD, *p < 0.01
versus control shRNA group). All data are repre-
sentative of two or three experiments. The boxed
areas represent expanded regions (magnified)
from the panels of the selected region by confocal
imaging.
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HMGB1 and Mitochondria Quality Controlet al., 2010; Yang and Klionsky, 2010). Mitophagy is responsible
for elimination of dysfunctional and impaired mitochondria (Kim
et al., 2007; Youle and Narendra, 2011). Mitophagy involves at
least a three-step process: (1) autophagosome formation to
engulf the dysfunctional mitochondria, (2) lysosome-autophago-
some fusion, and (3) degradation of dysfunctional mitochondria
by autolysosomes. Blocking the formation of autophagosomes
by 3-methyladenine (3-MA, class III phosphoinositide 3-kinase
inhibitor) (Stroikin et al., 2004), blocking the fusion of autophago-
somes with lysosomes by bafilomycin A1 (vacuolar ATPase
inhibitor) (Bjørkjøy et al., 2005), or blocking lysosomal degrada-
tion by pepstatin and E64D (lysosomal protease inhibitors)
(Mizushima and Yoshimori, 2007) increased rotenone-mediatedCATP depletion and mitochondrial fragmentation in MEF cells
(Figures S2A and S2B). In addition, autophagy inhibitors (e.g.,
3-MA and bafilomycin A1) decreased OCR and ECR (Fig-
ure S2C). Our findings support the notion that autophagy and
mitophagy are involved in sustaining mitochondrial respiration
and morphology after cellular stress and mitochondrial injury.
Inhibition of the mitochondrial respiratory chain complex I by
rotenone induces autophagy or apoptosis in a variety of cells
by mediating ATP depletion, generating reactive oxygen species
(ROS), or causing mitochondrial depolarization (Chen et al.,
2007; Clark et al., 2006; Moon et al., 2005) (Figure 6A). We
focused on the early stages of mitochondrial injury induced by
rotenone because autophagy preceded mitochondria-mediatedell Metabolism 13, 701–711, June 8, 2011 ª2011 Elsevier Inc. 705
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Figure 5. HSPB1 Expression Restores Cellular Bioenergetics and Mitochondrial Morphology in Hmgb1–/– MEFs
(A) Transient transfection of pcDNA4-HisMaxC-HSPB1 (HSPB1 cDNA) into Hmgb1/ MEFs increased HSPB1 protein expression after 48 hr as determined by
western blot assay. +/+, Hmgb1+/+ MEFs; /, Hmgb1/ MEFs; Control cDNA, pcDNA4-HisMaxC.
(B) Expression of HSPB1 rescues alterations in cellular bioenergetics in Hmgb1/MEFs. Cells were sequentially treated as indicatedwith oligomycin (Olig, 1 uM),
p-trifluoromethoxy carbonyl cyanide phenyl hydrazone (FCCP, 0.3 uM), 2-deoxyglucose (2DG, 100mM), and rotenone (Rote, 1 uM). OCR, indicative of OXPHOS,
and ECR, indicative of glycolysis, were monitored by using the Seahorse Bioscience Extracellular Flux Analyzer in real time (mean ± SD, n = 3). +/+, Hmgb1+/+
MEFs; /, Hmgb1/ MEFs.
(C) ATP levels were assessed in Hmgb1/MEFswith or without HSPB1 cDNA transfection. Data represent relative ATP levels, with Hmgb1+/+MEFs set as 100%
(mean ± SD, n = 3, *p < 0.01, ns, not significant). +/+, Hmgb1+/+ MEFs; /, Hmgb1/ MEFs.
(D) Mitochondrial morphology was evaluated by using an antibody against the mitochondrial complex I subunit, GRIM-19 (red). Mitochondrial fragmentation as
a percent of cells was quantified in 15–20 random fields (mean ± SD, *p < 0.01, ns, not significant). +/+, Hmgb1+/+ MEFs; /, Hmgb1/ MEFs. All data are
representative of two or three experiments. The boxed areas represent expanded regions (magnified) from the panels of the selected region by confocal imaging.
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HMGB1 and Mitochondria Quality Controlapoptosis in MEFs (Figures S2D and S2E). There was a signifi-
cant increase in mitochondrial fragmentation after rotenone
treatment in HMGB1- and HSPB1-deficient cells (Figures S2F
and S2G). The microtubule-associated protein light chain-3
(LC3), a mammalian homolog of Atg8, is thought to recruit mito-
chondria into autophagosomes. Loss of HMGB1 or HSPB1 in-
hibited amino acid- and ATP depletion-induced autophagy as
assessed by the expression of LC3-II (Figure 6C), LC3 punctae
(Figures S3A and S3B), and lysosomal-associated membrane
protein 2 (LAMP2) with LC3 colocalization (Figure S3D). Loss
of HMGB1 and HSPB1 also decrease the mitochondrial
membrane potential and increase apoptosis (Figure S3B). More-
over, autophagy inhibitors (e.g., 3-MA) increased rotenone-
induced apoptosis (Figure S3C), suggesting that autophagy
is a cell survival mechanism under stress. To determine whether
HMGB1 and HSPB1 specifically regulate mitophagy, we
assessed the process of mitophagy in the absence of HMGB1
or HSPB1. Indeed, loss of HMGB1 andHSPB1 decreased coloc-
alization of mitochondria not only with LC3, but also with LAMP2
(Figure 6A and Figure S4), suggesting that the loss of HMGB1 or
HSPB1 results in defective autophagy with secondary conse-
quences on mitochondria.
Ultrastructural EM analysis reveals that wild-type cells exhibit
normal mitochondrial morphology with fragments of mitochon-
dria present in some autophagosomes or lysosomes after706 Cell Metabolism 13, 701–711, June 8, 2011 ª2011 Elsevier Inc.mitochondrial injury induced by rotenone (Figure 6B). As ex-
pected, polyubiquitin-binding protein, sequestosome 1 (p62)
bodies and expression (Bjørkøy et al., 2005) are increased in
HMGB1- and HSPB1-deficient cells when rotenone-induced
autophagy is impaired (Figure 6C and Figures S5A and S5B). In
addition, the degradation of exogenously introduced p62 after
starvation is also impaired in HMGB1- andHSPB1-deficient cells
(Figure S5C).
A well-characterized function of HSPB1 is to interact with the
actin cytoskeleton (Lavoie et al., 1993a, 1993b), a dynamic struc-
ture that maintains cell shape, enables cellular locomotion and
plays important roles in the transport andmorphology of intracel-
lular vesicles and organelles including mitochondria (Boldogh
and Pon, 2006). Stress fibers, which are bundles of easily visual-
ized actin filaments, appear in response to rotenone-induced
mitochondrial injury. The colocalization of mitochondria and
actin is also increased after rotenone treatment in wild-type
cells (Figure 6A), indicating that such interactions are an
important regulatory mechanism after mitochondrial injury.
Similar to HMGB1 deficiency, treatment of wild-type cells with
the cytoskeleton inhibitor cytochalasin D (CytD) decreases
stress fibers and colocalization of mitochondria with actin, mito-
chondria with autophagosomes (e.g., LC3), and mitochondria
with autolysosomes (e.g., LAMP2) after mitochondrial injury (Fig-
ure 6A). Moreover, CytD increases rotenone-induced apoptosis
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Figure 6. HMGB1 and HSPB1 Regulate Mitophagy after Rotenone-Induced Disruption of Oxidative Phosphorylation
(A) Confocal microscopy colocalizes mitochondria with LC3, LAMP2, and actin in Hmgb1+/+ (+/+), Hmgb1/ (/), control shRNA, or HSPB1 shRNAMEFs with
or without rotenone (2 uM, 6 hr). Cytochalasin D (CytD, 1 uM, 6 hr) was used to inhibit actin polymerization. Images were acquired digitally from a randomly
selected pool of 10–15 fields under each condition. Quantitative analysis of colocalization (%) was performed. Representative images are shown in Figure S4. In
parallel, apoptosis was analyzed by the Annexin V-FITC apoptosis detection kit and mitochondrial membrane potential depolarization (the Hmgb1+/+ control
group was set as 1) was measured by JC-1 fluorescence. Data are expressed as mean ± SD (*p < 0.01, n = 3).
(B) Ultrastructural features assessed by electron microscopy in Hmgb1+/+, Hmgb1/, control shRNA, and HSPB1 shRNAMEFs with or without ATP depletion by
rotenone (2 uM, 4 hr). Arrows point to mitochondria in autophagosomes or autolysosomes which are not apparent in Hmgb1/ or HSPB1 knockdowns. The
boxed areas represent expanded regions (magnified) from the panels of the selected region by confocal imaging.
(C) ATP depletion by rotenone (2 uM, 6 hr) increased the expression of p-HSPB1 (Ser15 and Ser86) in Hmgb1+/+ (+/+) cells but not Hmgb1/ (/) cells. HSPB1
mutants (S15A, S86A) cannot restore the decreased LC3-II and increased p62 expression observed in Hmgb1/ cells after rotenone treatment.
(D) Cells as indicated were treated with rotenone (2 uM) for 6 hr and then cytoplasmic (Cyt) and mitochondrial (Mit) extracts from cells were separated by SDS-
PAGE. The blots were probed with antibody against Parkin, Cox IV, tubulin, VDAC1, and Pink1.
(E) Cells as indicated were treated with rotenone (2 uM) for 6 hr and then VDAC1 ubiquitylation was assayed by immunoprecipitation (IP) and western blot (IB).
(F) Cellular ATP levels andmitochondrial fragmentation was assayed in Hmgb1+/+ (+/+) and Hmgb1/ (/) cells transfected with HSPB1 vectors with or without
Pink1 or Parkin shRNA (mean ± SD, *p < 0.01, ns, not significant).
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Figure 7. Schematic of the Mechanism by which HMGB1 Modulates
Mitochondrial Respiration andMorphology by SustainingMitophagy
In wild-type cells, HMGB1 functions as a transcriptional regulator of HSPB1
gene expression. Phosphorylation of HSPB1 is necessary to regulate the actin
cytoskeleton, which affects the cellular transport of autophagy and mitophagy
in response to mitochondrial injury. Loss of either HMGB1 or HSPB1 results in
phenotypically similar deficient mitophagy typified by mitochondrial frag-
mentation, decreased aerobic respiration, and subsequent ATP production.
OXPHOS, oxidative phosphorylation.
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deficient cells undergoing mitochondrial injury restored the
interaction between mitochondria and the cytoskeleton and
increased the dynamic stages of autophagy (Figure S6).
In response to stress, phosphorylation and increased expres-
sion of HSPB1 modulates actin polymerization and reorganiza-
tion (Lavoie et al., 1993b; Rousseau et al., 1997). We next
explored whether alterations in the phosphorylation of HSPB1
(Ser15 and Ser86) influence autophagy. ATP depletion induced
by rotenone treatment increased the expression of pHSPB1
(both Ser15 and Ser86) in Hmgb1+/+ cells but not in Hmgb1/
cells (Figure 6C). Previous studies have demonstrated that these
phosphorylated HSPB1 mutations decreased F-actin stabiliza-
tion and had no influence on the chaperone activity of HSPB1
(Benndorf et al., 1994; Rogalla et al., 1999). Expression of phos-
phorylation-deficient mutants of HSPB1 (S15A and S86A),
however, did not restore the deficit in autophagy, ATP produc-
tion, or morphology, whereas wild-type HSPB1 cDNA did (Fig-
ure 6C and Figure S6). These findings suggest that both Ser15
and Ser86 are necessary for HSPB1-mediated autophagy.
Uponmitochondrial membrane depolarization, PTEN-induced
putative kinase 1 (Pink1), a kinase of the outer mitochondrial
membrane, induces Parkin translocation to stressed mitochon-
dria (Geisler et al., 2010; Narendra et al., 2008). Subsequently,
Parkin mediates the formation of ubiquitin chains on voltage-
dependent anion channel 1 (VDAC1). This leads to the recruit-
ment of the autophagy receptor p62, which in turn, by binding
to LC3, directs damaged mitochondria to the autophagosome
(Geisler et al., 2010). There has, however, been a contradictory
report showing that VDAC1may not be required for Parkin-medi-
ated mitophagy (Narendra et al., 2010). We found that loss of
HMGB1 or HSPB1 inhibited rotenone-induced Parkin transloca-
tion, VDAC1 ubiquitylation (Figures 6D and 6E and Figure S7A),
but not Parkin expression (Figures 1A, 2A, 3A, and 5A). More-
over, knockdown of Pink1 or Parkin abolish the HSPB1-restored
ATP production and reduced mitochondrial fragmentation in
Hmgb1/ cells (Figure 6F). These findings suggest that both
Pink1 and Parkin are required for both HSPB1 and HMGB1-
mediated mitophagy.
Although mitophagy is a well established mechanism neces-
sary for elimination of dysfunctional mitochondria and regulation
of mitochondrial quality in yeast or mammalian cells by media-
tors such as NIX (Sandoval et al., 2008), autophagy-related
gene 32 (Okamoto et al., 2009), OPA1 (Twig et al., 2008), and
DRP1 (Twig et al., 2008), it is unclear whether or how mitophagy
triggered by dysfunctional mitochondria is regulated by nuclear
mediators. Our findings indicate that the nuclear protein
HMGB1 modulates mitochondrial respiration and morphology
by helping to sustain autophagy in mitochondria maintenance
through regulation of HSPB1 gene expression (Figure 7). Phos-
phorylation of HSPB1 is necessary to regulate the actin cytoskel-
eton, which affects the dynamics of autophagy in response to
mitochondrial injury. Because loss of either HMGB1 or HSPB1
results in autophagy deficiency, increase in the number of
impaired mitochondria results in an apparent increase in mito-
chondrial fragmentation. Moreover, loss of HMGB1 or HSPB1
results in decreased aerobic respiration and subsequent ATP
production. Indeed, deletion of HMGB1 (Calogero et al., 1999)
or HSPB1 (Garrido, 2002) in mice results in early postembryonic708 Cell Metabolism 13, 701–711, June 8, 2011 ª2011 Elsevier Inc.lethality. HMGB1 is localized within the nucleus, but in several
cell types and environments, HMGB1 can be detected within
the cytoplasm and readily within the extracellular space (Lotze
and Tracey, 2005). Our recent studies demonstrated that both
extracellular (exogenous) and endogenous HMGB1 promote
autophagy and cell survival after application of cancer chemo-
therapeutic agents and nutritional depletion (Liu et al., 2011;
Tang et al., 2010a, 2010b). Cytoplasmic HMGB1 is a Beclin
1-binding protein active in autophagy (Kang et al., 2010a; Tang
et al., 2010b). Interestingly, rotenone-mediated mitochondrial
injury increased the expression of HMGB1 and HSPB1 in mito-
chondria (Figure S7B), although this change and its significance
in the regulation of autophagy and mitophagy is unknown.
The cellular cytoskeleton plays multiple roles in regulation of
both selective and nonselective autophagy (Monastyrska et al.,
2009). For example, histone deacetylase-6 (HDAC6) promotes
autophagy and mitophagy by assembling an F-actin network
that stimulates autophagosome-lysosome fusion and substrate
degradation (Lee et al., 2010). Interestingly, mitochondria
degradation in yeast involves both a selective and nonselective
process of autophagy (Kissova´ et al., 2007). Indeed, some
specific regulators of mitophagy also play roles in nonselective
autophagy. For example, Parkin-mediated K63-linked polyubi-
quitination is required for autophagic clearance of misfolded
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HMGB1 and Mitochondria Quality Controlproteins (Olzmann and Chin, 2008). Nix is important for ROS-
mediated autophagy induction (Ding et al., 2010). More recently,
the mammalian Atg1 homolog UNC-51-like kinase 1 (ULK1) has
been shown to be required for both autophagy and mitophagy
after starvation (Egan et al., 2011). Our findings suggest
that HMGB1 and HSPB1 coordinately regulate both macro-
autophagy and mitophagy after starvation and mitochondrial
injury. However, it is still unclear as to the actual mechanisms
by which selective and nonselective autophagy are regulated.
Delineation of discrete autophagic pathways will improve our
understanding of both mitophagy and autophagy and will also
enable development of therapeutic strategies to target diseases
such as Parkinson’s disease and cancer.
EXPERIMENTAL PROCEDURES
Reagents
The antibodies to HSP90, HSP70, HSP60, HSP40, HSF1, GFP, B cell leukemia
and lymphoma 2 (Bcl-2), and His-tag were obtained from Cell Signaling
Technology (Danvers, MA). The antibody to HSP110 was obtained from
Stressgen (Ann Arbor, MI). The antibodies to actin, Nix, and HSPB1 (HSP25/
27) were obtained from Sigma (St. Louis, MO). The antibodies to pHSPB1
(Ser15), pHSPB1 (Ser86), Pink1, Parkin, VDAC1, and ubiquitin were obtained
from Abcam (Cambridge, MA). The antibodies to HMGB1, microtubule-asso-
ciated proteins LC3-I and LC3-II, DRP1, MEN1, OPA1, and LAMP2 were
obtained from Novus (Littleton, CO). The antibodies to aB-crystallin, p62,
and FIS1were from Santa Cruz Technology (Santa Cruz, CA,). The antibodies
to the complex I subunits NDUFA9 and GRIM-19, complex II subunit 70 kDa
Fp, complex III subunit Core 2, complex IV subunit 1, complex V subunit a,
cytchrome C, ATP synthase b, and mitofilin were obtained from Mitosciences
(Eugene, OR). Hoechst 33342 and phalloidin were obtained from Invitrogen
(San Diego, California). All other chemical reagents were obtained from Sigma
(St. Louis, MO).
pEGFPN1-HMGB1 plasmid was a kind gift from Dr. George Hoppe (Cole
Eye Institute) (Hoppe et al., 2006). The pUNO1-HMGB1 plasmid was obtained
from InvivoGen. The pcDNA4-HisMaxC-HSPB1, pcDNA4-HisMaxC-S15A,
and pcDNA4-HisMaxC-S86A were kind gifts from Dr. Yoon-Jin Lee (Korea
Institute of Radiological and Medical Sciences)(Lee et al., 2005). pEGFPC1-
p62 plasmid was a kind gift from Dr. Eileen White (The Cancer Institute of
New Jersey) (Mathew et al., 2009). Mouse or human HSPB1 shRNA,
HMGB1 shRNA, Pink1 shRNA, and Parkin shRNA were obtained from Sigma.
A nuclear and cytoplasmic extraction kit and a mitochondria and membrane
isolation kit were obtained from Pierce (Rockford, IL).
Cell Culture
NIH-3T3 fibroblasts, Panc02, Panc2.03, and HCT116 cells were derived from
the American Type Culture Collection (Manassas, VA) or National Institutes of
Health (Bethesda, MD). Hmgb1+/+ and Hmgb1/ immortalizedmouse embry-
onic fibroblasts were a kind gift from Dr. Marco E. Bianchi (San Raffaele Insti-
tute, Italy) (Calogero et al., 1999). All cell lines were cultured in medium supple-
mented with 10% heat-inactivated fetal bovine serum, 2 mM glutamine and
penicillin-streptomycin mix (Invitrogen, final concentration 50 mg/ml each) in
a humidified incubator with 5% CO2 and 95% air.
Gene Transfection and RNAi
Expression vector transfection or shRNA transfection by using FuGENE HD
Transfection Reagent (Roche Applied Science, Stockholm, Sweden) or Lipo-
fectamine 2000 reagent (Life Technologies) were performed according to
the manufacturer’s instructions. siRNA was transfected into cells by using
X-tremeGENE siRNA reagent (Roche Applied Science) according to themanu-
facturer’s instructions. In general, the transfection efficiency is >80%.
Western Blotting
Proteins in cell lysates were resolved on 4%–12% Criterion XT Bis-Tris
gels (Bio-Rad) and transferred to a nitrocellulose membrane as previously
described (Tang et al., 2007a, 2007b). After blocking, the membrane was incu-Cbated overnight at 4C with various primary antibodies. After incubation
with peroxidase-conjugated secondary antibodies for 1 hr at 25C, signals
were visualized by enhanced chemiluminescence detection (Pierce) according
to the manufacturer’s instruction. The relative band intensities were quantified
by using the Gel-Pro Analyzer software (Media Cybernetics, Bethesda, MD).
Immunofluorescence Analysis
Cells were cultured on glass coverslips and fixed in 3% formaldehyde for
30 min at room temperature prior to detergent extraction with 0.1% Triton
X-100 for 10 min at 25C. Coverslips were saturated with 2% bovine serum
albumin (BSA) in phosphate-buffered saline (PBS) for 1 hr at room temperature
and processed for immunofluorescence with primary antibodies followed by
Alexa Fluor or Cy3-conjugated secondary antibodies, respectively. Nuclear
morphology was analyzed with the fluorescent dye Hoechst 33342. Actin
was stained with phalloidin. Mitochondria were stained by using anti-complex
I subunit GRIM-19 or anti-ATP synthase b. Between all incubation steps, cells
were washed three times for 3 min with 0.5% BSA in PBS. Images were taken
with an Olympus Fluoview 1000 confocal microscope (Olympus Corp., Tokyo,
Japan). Fluorescent intensities were measured by Image-Pro Plus platform
(Media Cybernetics, Bethesda, MD). The mitochondria of untreated cells
were filamentous and showed a thread-like tubular structure, while mitochon-
dria in stressed cells were fragmented and appeared shortened and punctate.
Quantification of mitochondrial fragmentation was performed as described
previously (Brooks et al., 2009).
Immunoprecipitation Analysis
Cells were lysed at 4C in ice-cold modified radioimmunoprecipitation lysis
buffer (Millipore, Billerica, MA) and cell lysates were cleared by centrifugation
at 12000 g for 10 min. Concentrations of proteins in the supernatant were
determined by bicinchoninic acid assay. Prior to immunoprecipitation,
samples containing equal amount of proteins were precleared with protein A
or protein G agarose or sepharose (Millipore) (4C, 3 hr) and subsequently
incubated with various irrelevant IgG or specific antibodies (2–5 mg/ml) in the
presence of protein A or G agarose or sepharose beads for 2 hr or overnight
at 4C with gentle shaking. After incubation, agarose or sepharose beads
were washed extensively with PBS and proteins were eluted by boiling in
2 3 sodium dodecyl sulfate (SDS) sample buffer before SDS-PAGE electro-
phoresis. To detect ubiquitylation of VDAC1, we immunoprecipitated cell
extracts with anti-VDAC1 antibody and analyzed them with an anti-ubiquitin
antibody followed by western blotting.
ATP Assay
The ATP content in whole-cell extracts was determined with a luminescent
ATP detection kit (ATPlite, PerkinElmer, Boston, MA) according to the manu-
facturer’s instructions. The luminescent intensity was measured by using a
microplate reader (Synergy 2, BioTek Instruments, Winooski, VT). In parallel,
the cell numbers in whole-cell samples were counted by trypan blue exclusion
assay. The results were expressed as relative ATP level compared with
controls after normalizing for cell numbers.
Autophagy Assays
The percentage of cells with LC3 punctae was determined by quantifying the
number of positively staining cells from 50–100 randomly chosen cells from
15–20 random fields. Autophagic flux assays were performed by western
blotting for LC3-I and LC3-II and p62, by imaging for the percentage of cells
with LC3 and p62 punctae, and by colocalization of LC3 with mitochondria,
actin with mitochondria, and LAMP2 with mitochondria. In brief, images
were collected by using a laser scanning confocal microscope (Fluoview FV-
1000, Olympus) with a 60 3 Plan Apo 1.45 oil immersion objective at 25C
and Fluoview software (FV10-ASW 1.6, Olympus). Images were subsequently
analyzed for fluorescent intensity levels and colocalization of various stains by
Image-Pro Plus 5.1 software (Media Cybernetics).
Transmission electron microscopic (TEM) assessment of autophagosomes
and autolysosomes was performed as previously described (Tang et al.,
2010b). In brief, cells were fixed with 2% paraformaldehyde and 2% glutaral-
dehyde in 0.1 mol/L phosphate buffer (pH 7.4), followed by incubation for 6 hr
in 1% OsO4. After dehydration with graded alcohols, the samples were
embedded in epoxy resin (Epon, Momentive Specialty Chemicals, Houston,ell Metabolism 13, 701–711, June 8, 2011 ª2011 Elsevier Inc. 709
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HMGB1 and Mitochondria Quality ControlTX). After embedding, thin sections (70 nm) were cut by using a microtome
(Leica Ultracut R), mounted on copper grids and poststained with 2% uranyl
acetate and 1% lead citrate, dried, and analyzed by using a TEM at 25C
(JEOL 100CX, Peabody, MA). Thick sections were cut (300 nm) and stained
with 1% toluidine blue. Images were acquired digitally from a randomly
selected pool of 10–15 fields under each condition.
Apoptosis Assays
Apoptosis in cells was assessed with the Annexin V-FITC Apoptosis Detection
Kit (BD PharMingen, San Jose, CA) by using flow cytometric analysis (Kang
et al., 2010c; Tang et al., 2010a) or a TUNEL kit from Roche Applied Science.
Mitochondrial membrane potential depolarization was measured by flow
cytometry with a fluorescent cationic dye, 1,103,30- tetraethylbenzamidazolo-
carbocyanin iodide (JC-1, Molecular Probes, San Diego, CA). JC-1 dye
exhibits potential-dependent accumulation in mitochondria, indicated by
a fluorescence emission shift from green (529 nm) to red (590 nm). Conse-
quently, mitochondrial depolarization is assessed by a decrease in the red/
green fluorescence intensity ratio.
Heat Shock Element Activation Assay
Cells were transiently transfected in a 12-well plate with an HSE luciferase
reporter plasmid and control empty plasmid by using Lipofectamine 2000
reagent (Invitrogen) according to the manufacturer’s instructions. After
24–48 hr, the cells were exposed to various treatments. Luciferase activity
was determined by using an assay system including the reporter lysis buffer
obtained from Promega (Madison, WI) as described previously (Wang et al.,
2002). The results were expressed as relative HSE activity after normalizing
for the control empty plasmid.
Oxidative Phosphorylation and Glycolysis Assay
Cellular OXPHOS and glycolysis weremonitoredwith the Seahorse Bioscience
Extracellular Flux Analyzer (XF24, Seahorse Bioscience Inc., North Billerica,
MA) by measuring the OCR (indicative of respiration) and ECR (indicative of
glycolysis) in real time as previously described (Qian and Van Houten, 2010;
Wu et al., 2007). Briefly, 30,000–50,000 cells were seeded in 24-well plates
designed for XF24 in 150 ml of appropriate growth media and incubated
overnight. Prior to measurements, cells were washed with unbuffered media
once, then immersed in 675 ml unbufferedmedia and incubated in the absence
ofCO2 for 1 hr. TheOCRandECRwere thenmeasured in a typical 8min cycle of
mix (2–4 min), dwell (2 min) and measure (2–4 min) as recommended by
SeahorseBioscience. Thebasal levels ofOCRandECRwere recorded first, fol-
lowed by the OCR and ECR levels after injection of compounds that inhibit the
respiratorymitochondrial electron transport chain, ATPsynthesis, or glycolysis.
Subcellular Fractionation and Organelle Isolation
Subcellular fractionation of cells was carried out according to the manufac-
turer’s instructions with a mitochondria, membrane, or nuclear isolation kit
obtained from Pierce (Rockford, IL).
Statistical Analysis
Data are expressed as means ± SD of two or three independent experiments
performed in triplicate. One-way ANOVA was used for comparison among the
different groups. When the ANOVA was significant, post hoc testing of differ-
ences between groups was performed by using an LSD test. A p value < 0.05
was considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and can be found with this
article online at doi:10.1016/j.cmet.2011.04.008.
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